Following a drop in investment caused by the financial crisis, venture capital (VC) investment in bio-based materials and chemicals (BBMC) came back with a boom. VC investment rose steadily and reached a peak of $1.3 billion in 2011. However, the lackluster performances of both public and private BBMC companies led investors to place smaller bets in recent investment. In this report, we dig into investment in the tumultuous BBMC space, analyzing VC, corporate VC, initial public offering (IPO) activity, and acquisitions.
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)